Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)
Gema Doménech, Esther Samper, Neus Llarch, Ana Matilla et al.
Citations
1 citations
Journal
Alimentary Pharmacology & Therapeutics
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
23.38
article
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)
Gema Doménech, Esther Samper, Neus Llarch, Ana Matilla, Gemma Iserte, Loreto Boix, A. J. García Guerrero, M. Heras Fortuny, Francesc Torres, Sergio Muñoz, Jordi Bruix, L. Carrión, Angels Kateb, Maria Reig, Marco Sanduzzi-Zamparelli, Ángeles García-Criado, B. Mínguez, Jordi Rimola, Laura Márquez, Andrés Castaño-García, José Luis Lledo, Mercedes Iñarrairaegui, José Rios-Guillermo
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Alimentary Pharmacology & TherapeuticsVol. 63(7)
Institutions
Universitat Autònoma de Barcelona (ES), Universidad de Oviedo (ES), Hospital General Universitario Gregorio Marañón (ES), Vall d'Hebron Institut de Recerca (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Clínic de Barcelona (ES), Vall d'Hebron Hospital Universitari (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Universitario Central de Asturias (ES), Clinica Universidad de Navarra (ES), Institute for Sustainability (GB), Fundació Clínic per a la Recerca Biomèdica (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Ramón y Cajal (ES), Universitat de Barcelona (ES)